Croup: Diagnosis and Management
Clinical Presentation and Diagnosis
Croup is a clinical diagnosis characterized by barking cough, inspiratory stridor, and respiratory distress in children aged 6 months to 6 years, typically preceded by upper respiratory symptoms. 1
Key Diagnostic Features
- Barking "seal-like" cough with low-grade fever and coryza 1
- Inspiratory stridor that worsens with agitation 2
- Median age of presentation is 23 months, with male predominance (63%) 3
- Parainfluenza viruses (types 1-3) are the most common causative agents, though identifying the specific pathogen does not alter treatment 3, 1
Clinical Assessment Priorities
Immediately assess severity indicators including: 3
- Ability to speak/cry normally
- Respiratory rate and heart rate
- Presence of stridor at rest
- Use of accessory muscles
- Oxygen saturation
- Life-threatening signs: silent chest, cyanosis, fatigue/exhaustion, or poor respiratory effort
Diagnostic Pitfalls to Avoid
- Radiographic studies are generally unnecessary and should be avoided unless there is concern for an alternative diagnosis 4, 3
- Always consider alternative diagnoses including bacterial tracheitis, epiglottitis, foreign body aspiration, retropharyngeal abscess, and peritonsillar abscess, particularly in patients who fail to respond to standard treatment 3
- Never perform blind finger sweeps in suspected foreign body aspiration, as this may push objects further into the pharynx 3
Treatment Algorithm
Mild Croup
All children with croup, regardless of severity, should receive oral corticosteroids immediately. 5, 4
- Dexamethasone 0.15-0.6 mg/kg orally (maximum 10-12 mg) as a single dose 4, 3
- Alternative: Prednisolone 1-2 mg/kg (maximum 40 mg) if dexamethasone unavailable 3
- Observe for 2-3 hours to ensure symptoms are improving 5
- No nebulized treatments needed for mild cases 5
Moderate to Severe Croup
For children with stridor at rest or significant respiratory distress: 4, 3
- Oral dexamethasone 0.15-0.6 mg/kg (maximum 10-12 mg) 4
- Add nebulized epinephrine 0.5 ml/kg of 1:1000 solution (maximum 5 ml) 5, 4
- Alternative: Nebulized budesonide 2 mg is equally effective as oral dexamethasone when oral administration is not feasible 4
Critical Management Considerations for Nebulized Epinephrine
- Effects last only 1-2 hours with risk of rebound symptoms 5, 3
- Observe for at least 2 hours after the last dose to assess for symptom rebound 5, 3
- Never use in outpatient settings where immediate return is not feasible or in children shortly to be discharged 5, 4, 3
- Never discharge within 2 hours of nebulized epinephrine administration 3
Hospitalization Criteria
The most recent American Academy of Pediatrics guidelines recommend considering hospitalization after 3 doses of nebulized epinephrine rather than the traditional 2 doses ("3 is the new 2" approach). 6, 5, 4
This evidence-based change:
- Reduces hospitalization rates by 37% without increasing revisits or readmissions 6, 4, 3
- Decreased admission rates from 8.7% to 5.5% in implementation studies 6
- Admission rate in patients receiving ≤2 epinephrine doses dropped from 6.3% to 1.7% (72% relative decrease) 6
Additional Admission Criteria
- Oxygen saturation <92% 4, 3
- Age <18 months 4, 3
- Respiratory rate >70 breaths/min 4, 3
- Persistent stridor at rest despite treatment 5
- Persistent difficulty in breathing 4
Supportive Care
Oxygen Therapy
- Administer oxygen to maintain saturation ≥94% via nasal cannula, head box, or face mask 4, 3
- Agitation may indicate hypoxemia requiring oxygen 3
- Monitor oxygen saturation at least every 4 hours for patients on oxygen therapy 3
Positioning
- For children under 2 years, use neutral head position with a roll under the shoulders to optimize airway patency 3
Comfort Measures
- Antipyretics can be used to keep the child comfortable 4, 3
- Minimal handling may reduce metabolic and oxygen requirements 4, 3
Ineffective Therapies to Avoid
- Humidified or cold air lacks evidence of benefit 3, 1, 7
- Chest physiotherapy is not beneficial and should not be performed 3
- Antibiotics should not be used routinely, as croup is typically viral 4
- Normal saline nebulization is not recommended as primary treatment 5
Discharge Criteria
Children may be discharged when: 4
- Resolution of stridor at rest
- Minimal or no respiratory distress
- Adequate oral intake
- Parents able to recognize worsening symptoms and return if needed
- Reliable family able to monitor and return if worsening 3
Discharge Instructions
- Review by general practitioner if deteriorating or not improving after 48 hours 4, 3
- Provide families with information on managing fever, preventing dehydration, and identifying signs of deterioration 3
- Ensure clear return precautions are provided 4
Special Considerations
Recurrent Croup
Consider asthma as a differential diagnosis in children with recurrent episodes, especially if: 3
- Cough worsens at night
- Episodes triggered by exercise or irritants
- Family history of asthma or atopy
- Presence of atopic dermatitis
- Consider prophylactic inhaled corticosteroids in these cases
When to Perform Bronchoscopy
Flexible bronchoscopy should be performed in cases of: 3
- Severe or persistent symptoms not responding to standard treatment
- Associated hoarseness
- Oxygen desaturation or apnea
- Atypical presentation raising concern for anatomic abnormality
- Up to 68% of infants with stridor have concomitant lower airway abnormalities requiring complete airway evaluation
Common Pitfalls Summary
- Admitting after only 1-2 doses of epinephrine when a third dose could be safely administered in the ED 4
- Discharging too early after nebulized epinephrine (before 2-hour observation) 5, 4, 3
- Failing to administer corticosteroids in mild cases 5, 4
- Using epinephrine in outpatient settings without adequate observation 5, 4
- Not providing clear return precautions to parents 4
- Ordering unnecessary neck radiographs 6, 4, 3